Worth Venture Partners’s Entera Bio Ltd. Warrant ENTXW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-302,644
Closed -$93.1K 105
2020
Q2
$82K Buy
+302,644
New +$122K 0.04% 107
2020
Q1
Sell
-279,819
Closed -$53K 121
2019
Q4
$53K Buy
279,819
+265,213
+1,816% +$52.1K 0.03% 77
2019
Q3
$7K Buy
14,606
+576
+4% +$372 ﹤0.01% 95
2019
Q2
$6K Buy
14,030
+87
+0.6% +$54 ﹤0.01% 89
2019
Q1
$13K Buy
+13,943
New +$12.6K 0.01% 89

Worth Venture Partners's ENTXW Position: Q3 2020 in Review

Worth Venture Partners sold out of Entera Bio Ltd. Warrant (ENTXW) in Q3 2020, closing a stake of 302,644 shares — an estimated $93.1K sold.

Worth Venture Partners first reported a position in ENTXW in Q1 2019 and held it in 5 quarters. The position peaked at $82K in Q2 2020. 2 funds tracked by Wall St. Rank hold ENTXW as of Q3 2020.

  • Worth Venture Partners reported no remaining Entera Bio Ltd. Warrant position as of Q3 2020 after selling out during the quarter.
  • Worth Venture Partners sold 302,644 Entera Bio Ltd. Warrant shares in Q3 2020, an estimated $93.1K.
  • Worth Venture Partners first reported a position in Entera Bio Ltd. Warrant in Q1 2019 and held it in 5 quarters.
  • Worth Venture Partners's Entera Bio Ltd. Warrant position peaked at $82K in Q2 2020.
  • 2 funds tracked by Wall St. Rank held Entera Bio Ltd. Warrant as of Q3 2020.

Based on Worth Venture Partners's 13F filing for Q3 2020, filed 16 Nov 2020.